Taal B G, Van Heerde P, Somers R
The Netherlands Cancer Institute, Department of Medical Oncology, Amsterdam.
Gut. 1993 Jul;34(7):994-8. doi: 10.1136/gut.34.7.994.
Primary oesophageal involvement by lymphoma in two patients, one with Hodgkin's disease and one with non-Hodgkin's lymphoma is reported. In both, there were no manifestations of the disease outside the oesophagus, which is exceptionally rare. In the patient with non-Hodgkin's lymphoma, the oesophageal tumour was the first manifestation of lymphoma. Shortly after admission he developed a tracheo-oesophageal fistula from which he died before treatment could be started. In the patient with Hodgkin's disease, isolated oesophageal lymphoma was the first relapse after a 13 year interval free of disease. As he had previously received mediastinal irradiation he was treated with combination chemotherapy that resulted in long term survival (> five years). Several other long term survivors have been described but only after radiotherapy or surgery. These findings suggest that systemic chemotherapy may be equally successful in treating isolated primary oesophageal lymphoma, thus offering an alternative for those patients in whom local treatment is contraindicated.
报告了两名淋巴瘤原发性食管受累的患者,一名患有霍奇金病,另一名患有非霍奇金淋巴瘤。在这两名患者中,食管外均无该疾病的表现,这极为罕见。在患有非霍奇金淋巴瘤的患者中,食管肿瘤是淋巴瘤的首发表现。入院后不久,他出现了气管食管瘘,并在开始治疗前死亡。在患有霍奇金病的患者中,孤立性食管淋巴瘤是在无病间隔13年后的首次复发。由于他之前接受过纵隔放疗,因此接受了联合化疗,从而获得了长期生存(>5年)。还描述了其他几名长期幸存者,但均是在放疗或手术后。这些发现表明,全身化疗在治疗孤立性原发性食管淋巴瘤方面可能同样成功,从而为那些禁忌局部治疗的患者提供了一种替代方法。